ScholarIQanswers from OpenAlex & ORCID
Randi J. Hagerman
ResearcherPublications, citations & collaboration network
Randi J. Hagerman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Randi J. Hagerman have?
ScholarIQindexed works
Randi J. Hagerman has 806 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Randi J. Hagerman have?
ScholarIQcitation count
Randi J. Hagerman has 44,728 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Randi J. Hagerman?
ScholarIQh-index
Randi J. Hagerman has an h-index of 115 in OpenAlex.
What is the i10-index of Randi J. Hagerman?
ScholarIQi10-index
Randi J. Hagerman has an i10-index of 476 in OpenAlex.
What is the ORCID of Randi J. Hagerman?
ScholarIQorcid
The ORCID for Randi J. Hagerman is on the source record.
What is the OpenAlex record for Randi J. Hagerman?
ScholarIQopenalex
The OpenAlex for Randi J. Hagerman is on the source record.
What are the most-cited papers on Randi J. Hagerman?
ScholarIQmost cited works
Fragile X Premutation Tremor/Ataxia Syndrome: Molecular, Clinical, and Neuroimaging Correlates
Sébastien Jacquemont, Randi J. Hagerman, Maureen A. Leehey, Jim Grigsby, Lin Zhang, James A. Brunberg, Claudia Greco, Vincent des Portes, Tristan Jardini, Richard A. Levine, Elizabeth Berry‐Kravis, W. Ted Brown, S. Schaeffer, John T. Kissel, Flora Tassone, Paul J. Hagerman
Epigenetic Modification of the <i>FMR1</i> Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056
Sébastien Jacquemont, Aurore Curie, Vincent des Portes, Maria Giulia Torrioli, Elizabeth Berry‐Kravis, Randi J. Hagerman, Feliciano J. Ramos, Kim Cornish, Yunsheng He, Charles Paulding, Giovanni Neri, Fei Chen, Nouchine Hadjikhani, Danielle Martinet, Joanne Meyer, J. Beckmann, Delange Karine, Brun Amandine, Gérald Bussy, F. Gasparini, Talita Hilse, Annette Floesser, Janice Branson, Graeme Bilbe, Donald R. Johns, Baltazar Gomez‐Mancilla
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Elizabeth Berry‐Kravis, Lothar Lindemann, Aia Elise Jønch, George Apostol, Mark F. Bear, Randall L. Carpenter, Jacqueline N. Crawley, Aurore Curie, Vincent des Portes, Farah Hossain, F. Gasparini, Baltazar Gomez‐Mancilla, David Hessl, Eva Loth, Sebastian H. Scharf, Paul P. Wang, Florian von Raison, Randi J. Hagerman, Will Spooren, Sébastien Jacquemont
Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial
Elizabeth Berry‐Kravis, David Hessl, Barbara Rathmell, Peter Zarevics, Maryann Cherubini, Karen Walton–Bowen, Yi Mu, Danh V. Nguyen, Joseph Gonzalez–Heydrich, Paul P. Wang, Randall L. Carpenter, Mark F. Bear, Randi J. Hagerman
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
Elizabeth Berry‐Kravis, Vincent des Portes, Randi J. Hagerman, Sébastien Jacquemont, Perrine Charles, Jeannie Visootsak, Marc Brinkman, K. Rérat, Barbara Koumaras, Liansheng Zhu, Gottfried Maria Barth, Thomas Jaecklin, George Apostol, Florian von Raison